US FDA Neurology Drugs Program Gains Boost In FY 2023 Funding Bill Amid Calls To Clarify Development Policies

 
• By Derrick Gingery
  
budget
Lawmakers also mandated an FDA report on Russian application sponsors in the appropriations bill. • Source: Shutterstock

More from US FDA

More from Agency Leadership